Andres M. Poveda
Impact in
- Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment
- Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments
Papers in
-
- Ovarian cancer diagnosis and treatment 58
-
- Endometrial and Cervical Cancer Treatments 26
- Co-authors
- Ignace B. Vergote (12 shared papers)Eric Pujade Lauraine (11 shared papers)Isabelle L. Ray-Coquard (7 shared papers)Felix Hilpert (5 shared papers)Petronella Oda Witteveen (4 shared papers)Aristotelis Bamias (4 shared papers)Alexander Reuß (3 shared papers)Javier Martín‐Broto (22 shared papers)
- Journals
- Annals of Oncology (27 papers)International Journal of Gynecological Cancer (17 papers)Gynecologic Oncology (13 papers)Journal of Clinical Oncology (10 papers)European Journal of Cancer (9 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Andres M. Poveda
139 papers receiving 9.9k citations
Andres M. Poveda's Hit Papers
Peers
Comparison fields: 5 of 124
- Reproductive Medicine 3.6k
- Obstetrics and Gynecology 1.4k
- Oncology 4.0k
- Gastroenterology 766
- Pulmonary and Respiratory Medicine 2.2k
Countries citing papers authored by Andres M. Poveda
This map shows the geographic impact of Andres M. Poveda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andres M. Poveda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andres M. Poveda more than expected).
Fields of papers citing papers by Andres M. Poveda
This network shows the impact of papers produced by Andres M. Poveda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andres M. Poveda. The network helps show where Andres M. Poveda may publish in the future.
Co-authors
The 25 scholars most cited alongside Andres M. Poveda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 1562 |
| 2 | Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial Hit paper breakdown → | 2014 | 1298 |
| 3 | Standard chemotherapy with or without bevacizumab for women with newly diagnosed ovarian cancer (ICON7): overall survival results of a phase 3 randomised trial Hit paper breakdown → | 2015 | 700 |
| 4 | 2008 | 401 | |
| 5 | 2010 | 332 | |
| 6 | Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial Hit paper breakdown → | 2021 | 319 |
| 7 | 2005 | 297 | |
| 8 | 2014 | 255 | |
| 9 | 2011 | 243 | |
| 10 | 2015 | 191 | |
| 11 | 2003 | 162 | |
| 12 | 2011 | 157 | |
| 13 | Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial Hit paper breakdown → | 2023 | 147 |
| 14 | 2012 | 146 | |
| 15 | 2010 | 129 | |
| 16 | 2012 | 122 | |
| 17 | 2014 | 114 | |
| 18 | 2016 | 112 | |
| 19 | 2017 | 112 | |
| 20 | 2014 | 96 |
About Andres M. Poveda
Andres M. Poveda is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 142 papers that have together received 10.2k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (58 papers), Sarcoma Diagnosis and Treatment (32 papers), Endometrial and Cervical Cancer Treatments (26 papers), PARP inhibition in cancer therapy (25 papers), Gastrointestinal Tumor Research and Treatment (21 papers), BRCA gene mutations in cancer (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). The work is most often cited by research in Reproductive Medicine (3.6k citations), Obstetrics and Gynecology (1.4k citations), Oncology (4.0k citations), Gastroenterology (766 citations) and Pulmonary and Respiratory Medicine (2.2k citations). Andres M. Poveda has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Ignace B. Vergote, Eric Pujade Lauraine, Isabelle L. Ray-Coquard, Felix Hilpert, Petronella Oda Witteveen, Aristotelis Bamias, Alexander Reuß, Javier Martín‐Broto, Ana Oaknin and José Antonio López‐Guerrero. Their work appears in journals such as Annals of Oncology, International Journal of Gynecological Cancer, Gynecologic Oncology, Journal of Clinical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.